[Risk factors of tuberculosis in children]

C Delacourt1

  • 1Service de pédiatrie, 94000 Créteil, France. Christophe.delacourt@chicreteil.fr

Insights

Understanding tuberculosis risk factors in children is crucial for targeted screening and tailored treatment. Identifying high-risk exposures and host factors aids in preventing latent infection progression.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Epidemiology

Context:

  • Accurate identification of children requiring tuberculosis screening and risk-stratified treatment necessitates a thorough understanding of infection and disease progression risk factors.
  • Tuberculosis infection risk is primarily influenced by the extent and duration of exposure, with household contacts posing the highest risk.
  • Host factors such as young age and chronic illnesses increase the likelihood of disease progression but not initial infection.

Purpose:

  • To elucidate the key risk factors associated with latent tuberculosis infection (LTBI) and its progression to active disease in pediatric populations.
  • To inform the development of targeted screening strategies and individualized treatment approaches for children.
  • To evaluate the potential of adapting tuberculin skin test (TST) criteria based on risk to improve test accuracy.

Summary:

  • Tuberculosis (TB) infection risk in children is strongly linked to exposure intensity and duration, particularly within household settings.
  • While host factors like young age and chronic conditions do not elevate infection rates, they significantly promote progression from latent infection to active disease.
  • Modifying TST interpretation criteria according to individual risk may enhance its predictive values, guiding decisions on prophylactic treatment for high-risk children.

Impact:

  • Improved targeting of tuberculosis screening in pediatric populations, leading to earlier diagnosis and intervention.
  • Personalized treatment strategies based on identified risk factors, potentially reducing disease progression and transmission.
  • Enhanced diagnostic accuracy of the tuberculin skin test through risk-adjusted interpretation, optimizing clinical decision-making.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...